Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-048712
Filing Date
2021-07-29
Accepted
2021-07-29 21:33:49
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5667
2 POA DOCUMENT poa.txt EX-24.3_1001121 3556
  Complete submission text file 0001209191-21-048712.txt   10682
Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IN8BIO, INC. 79 MADISON AVENUE NEW YORK NY 10016
Business Address
Beelen Melissa (Reporting) CIK: 0001829992 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 211129731